Saab shares continue to go from strength to strength. Q117 results confirm the company is on track to achieve above targeted organic sales development in the near term. Order intake remains positive and prospects for the new and upgraded versions of the Gripen fighter aircraft remain strong, aided by the improving trends in defence spending. The shares are trading once again at record levels, and the rating requires a continuing conversion of the pipeline into firm activity.


Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Prize fighter
Saab shares continue to go from strength to strength. Q117 results confirm the company is on track to achieve above targeted organic sales development in the near term. Order intake remains positive and prospects for the new and upgraded versions of the Gripen fighter aircraft remain strong, aided by the improving trends in defence spending. The shares are trading once again at record levels, and the rating requires a continuing conversion of the pipeline into firm activity.